Malignant Neoplasms, Brain
Showing 1 - 25 of >10,000
Malignant Brain Tumor, Glioma, Coping Skills Trial in Boston (Information and Support Intervention, Usual supportive care)
Not yet recruiting
- Malignant Brain Tumor
- +2 more
- Information and Support Intervention
- Usual supportive care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jul 27, 2023
Circulating and Tumor-infiltrating Immune Cells in Malignant
Recruiting
- Brain Tumor, Primary
- Brain Tumor - Metastatic
- Circulating leukocytes immunophenotype
- Tumor sampling
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Apr 14, 2023
Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor
Not yet recruiting
- Pediatric Brain Tumor
- +2 more
- Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
- Implantation
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 24, 2023
Malignant Brain Tumors Trial in Berkel en Rodenrijs (procedure, device, other)
Recruiting
- Malignant Brain Tumors
- intra-arterial injection
- +2 more
-
Berkel en Rodenrijs, Zuid Holland, NetherlandsLaurens Groenendijk
Apr 3, 2023
Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing
Recruiting
- Medulloblastoma
- +5 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hosiptal
Jan 3, 2023
Human Brain-Gut Axis and Gut Microbiome in Brain Lesions -
Not yet recruiting
- Malignant Central Nervous System Neoplasm
- Non-Interventional Study
-
Jacksonville, FloridaMayo Clinic in Florida
Oct 31, 2023
5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for
Not yet recruiting
- High Grade Glioma
- +10 more
- 5-Aminolevulinic Acid (5-ALA) Gliolan®
- Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 28, 2023
Malignant Brain Tumor, Malignant Glioma, Embryonal Tumor Trial in Paris, Villejuif (SonoCloud® (9 transducers))
Not yet recruiting
- Malignant Brain Tumor
- +2 more
- SonoCloud® (9 transducers)
-
Paris, France
- +2 more
Sep 26, 2022
Malignant Brain Tumor, Glioma, Coping Skills Trial in Boston (Psychosocial intervention, Usual supportive care)
Not yet recruiting
- Malignant Brain Tumor
- +3 more
- Psychosocial intervention
- Usual supportive care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Oct 19, 2023
Primary Malignant Brain Tumor Trial in China (ABM-1310)
Not yet recruiting
- Primary Malignant Brain Tumor
-
Beijing, Beijing, China
- +3 more
May 28, 2023
Astroblastoma, BCOR ITD Sarcoma, CNS Sarcoma Trial in Washington
Recruiting
- Astroblastoma
- +3 more
-
Washington, District of ColumbiaChildren's National Hospital
Jan 23, 2023
Malignant Brain Tumor Trial in Saint-Jean (NODDI TRACT)
Not yet recruiting
- Malignant Brain Tumor
- NODDI TRACT
-
Saint-Jean, FranceClinique de l'Union
Dec 20, 2022
AI R&D Tool in Adult Glioma and Other Primary Brain Tumours
Not yet recruiting
- Brain Tumor
- +4 more
- Resection
-
London, United KingdomImperial College Healthcare NHS Trust
Sep 15, 2023
Malignant Glioma, Anxiety, Caregiver Burden Trial in Boston (Psychosocial Intervention Group, Usual Care Group)
Active, not recruiting
- Malignant Glioma
- +3 more
- Psychosocial Intervention Group
- Usual Care Group
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jul 12, 2022
Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial
Recruiting
- Glioma, Malignant
- +6 more
- Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 13, 2023
Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)
Recruiting
- Glioma
- +7 more
- Laparoscopically harvested omental tissue autograft
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 31, 2023
Benign Brain Tumor, Malignant Brain Tumor Trial in Toronto, Seoul (cCeLL Ex Vivo)
Not yet recruiting
- Benign Brain Tumor
- Malignant Brain Tumor
- cCeLL Ex Vivo
-
Toronto, Ontario, Canada
- +3 more
Oct 18, 2023
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,
Not yet recruiting
- Diffuse Astrocytoma, IDH-Mutant
- +20 more
- NEO212 Oral Capsule
- +8 more
- (no location specified)
Sep 18, 2023
Supramaximal Resection Versus Maximal Resection for High-Grade
Recruiting
- Glioblastoma
- +11 more
- Supramaximal resection
- Maximal safe resection
-
San Francisco, California
- +7 more
Nov 1, 2023
Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)
Terminated
- Brain and Central Nervous System Tumors
- thalidomide
- topotecan hydrochloride
-
Chicago, IllinoisRush Cancer Institute at Rush University Medical Center
Jan 5, 2023
Newly Diagnosed or Recurrent Metastatic Melanoma Patients, Malignant Brain Tumors Trial in New York (PET scan with
Active, not recruiting
- Newly Diagnosed or Recurrent Metastatic Melanoma Patients
- Malignant Brain Tumors
- PET scan with 124I-cRGDY-PEG-dots
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 13, 2022
Malignant Tumor, Malignant Tumor of Brain Trial in Taiwan (NBM-BMX Capsule, Temozolomide, Standard radiotherapy)
Recruiting
- Malignant Neoplasm
- Malignant Neoplasm of Brain
- NBM-BMX Capsule
- +2 more
-
Hualien City, Taiwan
- +4 more
Aug 22, 2023
Patients With Brain Tumors Undergoing Surgery
Recruiting
- Central Nervous System Neoplasm
- +3 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 29, 2022
Intracranial Tumor Trial in Portland (Magnetic Resonance Imaging, Oxygen Therapy)
Recruiting
- Intracranial Neoplasm
- Magnetic Resonance Imaging
- Oxygen Therapy
-
Portland, OregonOHSU Knight Cancer Institute
Jun 6, 2023
Metastatic Malignant Tumor in the Brain Trial in Columbus (other, procedure, drug, radiation)
Active, not recruiting
- Metastatic Malignant Neoplasm in the Brain
- Laboratory Biomarker Analysis
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 15, 2022